nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—PTGS2—ovarian follicle—polycystic ovary syndrome	0.0277	0.184	CbGeAlD
Etodolac—Abnormal faeces—Metformin—polycystic ovary syndrome	0.0248	0.148	CcSEcCtD
Etodolac—UGT1A10—endocrine gland—polycystic ovary syndrome	0.0152	0.101	CbGeAlD
Etodolac—CYP2C9—urine—polycystic ovary syndrome	0.0133	0.0882	CbGeAlD
Etodolac—UGT1A3—endocrine gland—polycystic ovary syndrome	0.0107	0.0713	CbGeAlD
Etodolac—Heartburn—Metformin—polycystic ovary syndrome	0.0103	0.0613	CcSEcCtD
Etodolac—RXRA—female gonad—polycystic ovary syndrome	0.00975	0.0649	CbGeAlD
Etodolac—RXRA—endocrine gland—polycystic ovary syndrome	0.00907	0.0604	CbGeAlD
Etodolac—UGT1A9—endocrine gland—polycystic ovary syndrome	0.00764	0.0508	CbGeAlD
Etodolac—UGT2B7—endocrine gland—polycystic ovary syndrome	0.00615	0.0409	CbGeAlD
Etodolac—Renal impairment—Metformin—polycystic ovary syndrome	0.00542	0.0322	CcSEcCtD
Etodolac—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00471	0.028	CcSEcCtD
Etodolac—Abdominal distension—Metformin—polycystic ovary syndrome	0.00449	0.0267	CcSEcCtD
Etodolac—Pancreatitis—Metformin—polycystic ovary syndrome	0.00437	0.026	CcSEcCtD
Etodolac—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00427	0.0254	CcSEcCtD
Etodolac—Neutropenia—Metformin—polycystic ovary syndrome	0.00417	0.0248	CcSEcCtD
Etodolac—ALB—adrenal gland—polycystic ovary syndrome	0.00406	0.027	CbGeAlD
Etodolac—PTGS2—embryo—polycystic ovary syndrome	0.00374	0.0249	CbGeAlD
Etodolac—Rhinitis—Metformin—polycystic ovary syndrome	0.00358	0.0212	CcSEcCtD
Etodolac—Hepatitis—Metformin—polycystic ovary syndrome	0.00357	0.0212	CcSEcCtD
Etodolac—Flushing—Metformin—polycystic ovary syndrome	0.00331	0.0197	CcSEcCtD
Etodolac—Chills—Metformin—polycystic ovary syndrome	0.0032	0.019	CcSEcCtD
Etodolac—PTGS2—adrenal cortex—polycystic ovary syndrome	0.00307	0.0204	CbGeAlD
Etodolac—Flatulence—Metformin—polycystic ovary syndrome	0.00306	0.0182	CcSEcCtD
Etodolac—Dysgeusia—Metformin—polycystic ovary syndrome	0.00304	0.0181	CcSEcCtD
Etodolac—Vision blurred—Metformin—polycystic ovary syndrome	0.00293	0.0174	CcSEcCtD
Etodolac—Tremor—Metformin—polycystic ovary syndrome	0.00291	0.0173	CcSEcCtD
Etodolac—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00288	0.0171	CcSEcCtD
Etodolac—PTGS1—endometrium—polycystic ovary syndrome	0.00286	0.0191	CbGeAlD
Etodolac—Malaise—Metformin—polycystic ovary syndrome	0.0028	0.0166	CcSEcCtD
Etodolac—Syncope—Metformin—polycystic ovary syndrome	0.00278	0.0165	CcSEcCtD
Etodolac—Palpitations—Metformin—polycystic ovary syndrome	0.00274	0.0163	CcSEcCtD
Etodolac—PTGS2—endometrium—polycystic ovary syndrome	0.00274	0.0182	CbGeAlD
Etodolac—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00273	0.0162	CcSEcCtD
Etodolac—Hypertension—Metformin—polycystic ovary syndrome	0.00268	0.0159	CcSEcCtD
Etodolac—Myalgia—Metformin—polycystic ovary syndrome	0.00264	0.0157	CcSEcCtD
Etodolac—PTGS1—uterus—polycystic ovary syndrome	0.00264	0.0176	CbGeAlD
Etodolac—Discomfort—Metformin—polycystic ovary syndrome	0.00261	0.0155	CcSEcCtD
Etodolac—PTGS1—pituitary gland—polycystic ovary syndrome	0.00259	0.0172	CbGeAlD
Etodolac—PTGS1—adipose tissue—polycystic ovary syndrome	0.00258	0.0172	CbGeAlD
Etodolac—Oedema—Metformin—polycystic ovary syndrome	0.00253	0.0151	CcSEcCtD
Etodolac—PTGS2—uterus—polycystic ovary syndrome	0.00252	0.0168	CbGeAlD
Etodolac—Infection—Metformin—polycystic ovary syndrome	0.00252	0.015	CcSEcCtD
Etodolac—Shock—Metformin—polycystic ovary syndrome	0.00249	0.0148	CcSEcCtD
Etodolac—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00248	0.0147	CcSEcCtD
Etodolac—PTGS2—pituitary gland—polycystic ovary syndrome	0.00248	0.0165	CbGeAlD
Etodolac—PTGS2—adipose tissue—polycystic ovary syndrome	0.00247	0.0164	CbGeAlD
Etodolac—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00245	0.0146	CcSEcCtD
Etodolac—Anorexia—Metformin—polycystic ovary syndrome	0.00242	0.0144	CcSEcCtD
Etodolac—Hypotension—Metformin—polycystic ovary syndrome	0.00237	0.0141	CcSEcCtD
Etodolac—PTGS1—adrenal gland—polycystic ovary syndrome	0.00232	0.0154	CbGeAlD
Etodolac—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00231	0.0137	CcSEcCtD
Etodolac—Paraesthesia—Metformin—polycystic ovary syndrome	0.00228	0.0135	CcSEcCtD
Etodolac—Dyspnoea—Metformin—polycystic ovary syndrome	0.00226	0.0134	CcSEcCtD
Etodolac—Somnolence—Metformin—polycystic ovary syndrome	0.00225	0.0134	CcSEcCtD
Etodolac—Dyspepsia—Metformin—polycystic ovary syndrome	0.00223	0.0133	CcSEcCtD
Etodolac—PTGS2—adrenal gland—polycystic ovary syndrome	0.00221	0.0147	CbGeAlD
Etodolac—Decreased appetite—Metformin—polycystic ovary syndrome	0.0022	0.0131	CcSEcCtD
Etodolac—CYP2C9—endocrine gland—polycystic ovary syndrome	0.0022	0.0146	CbGeAlD
Etodolac—Fatigue—Metformin—polycystic ovary syndrome	0.00218	0.013	CcSEcCtD
Etodolac—Constipation—Metformin—polycystic ovary syndrome	0.00217	0.0129	CcSEcCtD
Etodolac—PTGS1—female gonad—polycystic ovary syndrome	0.00216	0.0144	CbGeAlD
Etodolac—PTGS1—vagina—polycystic ovary syndrome	0.00215	0.0143	CbGeAlD
Etodolac—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00209	0.0124	CcSEcCtD
Etodolac—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00207	0.0123	CcSEcCtD
Etodolac—PTGS2—female gonad—polycystic ovary syndrome	0.00206	0.0137	CbGeAlD
Etodolac—PTGS2—vagina—polycystic ovary syndrome	0.00205	0.0136	CbGeAlD
Etodolac—Urticaria—Metformin—polycystic ovary syndrome	0.00201	0.012	CcSEcCtD
Etodolac—PTGS1—endocrine gland—polycystic ovary syndrome	0.00201	0.0134	CbGeAlD
Etodolac—Abdominal pain—Metformin—polycystic ovary syndrome	0.002	0.0119	CcSEcCtD
Etodolac—PTGS2—endocrine gland—polycystic ovary syndrome	0.00192	0.0128	CbGeAlD
Etodolac—Asthenia—Metformin—polycystic ovary syndrome	0.00182	0.0108	CcSEcCtD
Etodolac—Pruritus—Metformin—polycystic ovary syndrome	0.00179	0.0107	CcSEcCtD
Etodolac—Diarrhoea—Metformin—polycystic ovary syndrome	0.00173	0.0103	CcSEcCtD
Etodolac—Dizziness—Metformin—polycystic ovary syndrome	0.00168	0.00996	CcSEcCtD
Etodolac—Vomiting—Metformin—polycystic ovary syndrome	0.00161	0.00957	CcSEcCtD
Etodolac—Rash—Metformin—polycystic ovary syndrome	0.0016	0.00949	CcSEcCtD
Etodolac—Dermatitis—Metformin—polycystic ovary syndrome	0.0016	0.00949	CcSEcCtD
Etodolac—Headache—Metformin—polycystic ovary syndrome	0.00159	0.00943	CcSEcCtD
Etodolac—Nausea—Metformin—polycystic ovary syndrome	0.0015	0.00894	CcSEcCtD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000176	0.000259	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—INS—polycystic ovary syndrome	0.000173	0.000254	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000173	0.000254	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IL6—polycystic ovary syndrome	0.000173	0.000254	CbGpPWpGaD
Etodolac—RXRA—Metabolism—RRM2—polycystic ovary syndrome	0.000171	0.000251	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00017	0.00025	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—NAMPT—polycystic ovary syndrome	0.00017	0.00025	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.00017	0.000249	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000169	0.000248	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000169	0.000248	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CYP11A1—polycystic ovary syndrome	0.000168	0.000247	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000168	0.000246	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—AKT2—polycystic ovary syndrome	0.000167	0.000246	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000166	0.000244	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—HMMR—polycystic ovary syndrome	0.000166	0.000243	CbGpPWpGaD
Etodolac—PTGS2—Disease—RPL37A—polycystic ovary syndrome	0.000166	0.000243	CbGpPWpGaD
Etodolac—RXRA—Metabolism—YAP1—polycystic ovary syndrome	0.000165	0.000242	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000163	0.00024	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000163	0.00024	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000163	0.00024	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000161	0.000237	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000161	0.000236	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—TH—polycystic ovary syndrome	0.000159	0.000233	CbGpPWpGaD
Etodolac—RXRA—Metabolism—NAMPT—polycystic ovary syndrome	0.000159	0.000233	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—AKR1C3—polycystic ovary syndrome	0.000159	0.000233	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000158	0.000232	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000158	0.000232	CbGpPWpGaD
Etodolac—ALB—Metabolism—TEAD2—polycystic ovary syndrome	0.000158	0.000231	CbGpPWpGaD
Etodolac—ALB—Metabolism—AKR1C2—polycystic ovary syndrome	0.000158	0.000231	CbGpPWpGaD
Etodolac—PTGS2—Disease—HMMR—polycystic ovary syndrome	0.000157	0.000231	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CYP11A1—polycystic ovary syndrome	0.000157	0.00023	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000156	0.000229	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CYP17A1—polycystic ovary syndrome	0.000156	0.000229	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000156	0.000228	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000155	0.000227	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000155	0.000227	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000154	0.000226	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000152	0.000223	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000152	0.000222	CbGpPWpGaD
Etodolac—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000151	0.000222	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PLAT—polycystic ovary syndrome	0.000151	0.000221	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—RRM2—polycystic ovary syndrome	0.000149	0.000219	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000149	0.000219	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000148	0.000218	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000148	0.000218	CbGpPWpGaD
Etodolac—RXRA—Metabolism—AKR1C3—polycystic ovary syndrome	0.000148	0.000217	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—STAR—polycystic ovary syndrome	0.000148	0.000217	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000146	0.000214	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CYP17A1—polycystic ovary syndrome	0.000146	0.000214	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	0.000145	0.000214	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CYP19A1—polycystic ovary syndrome	0.000145	0.000213	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	0.000145	0.000213	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—AR—polycystic ovary syndrome	0.000144	0.000212	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—LHB—polycystic ovary syndrome	0.000144	0.000212	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—YAP1—polycystic ovary syndrome	0.000144	0.000211	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000141	0.000207	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00014	0.000206	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000138	0.000203	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—NAMPT—polycystic ovary syndrome	0.000138	0.000203	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	0.000138	0.000203	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000137	0.000202	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000137	0.000201	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000137	0.0002	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000137	0.0002	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000136	0.000199	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—TH—polycystic ovary syndrome	0.000135	0.000198	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000134	0.000197	CbGpPWpGaD
Etodolac—ALB—Metabolism—PNPLA2—polycystic ovary syndrome	0.000132	0.000194	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000132	0.000194	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	0.000132	0.000193	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—SLC2A4—polycystic ovary syndrome	0.000131	0.000193	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000131	0.000193	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000131	0.000192	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GNAS—polycystic ovary syndrome	0.00013	0.00019	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	0.000129	0.00019	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000129	0.000189	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000129	0.000189	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000129	0.000189	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000127	0.000186	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—NCOR1—polycystic ovary syndrome	0.000126	0.000185	CbGpPWpGaD
Etodolac—RXRA—Metabolism—TH—polycystic ovary syndrome	0.000126	0.000185	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000126	0.000184	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000126	0.000184	CbGpPWpGaD
Etodolac—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	0.000125	0.000184	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000124	0.000182	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000124	0.000182	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—NCOR1—polycystic ovary syndrome	0.000124	0.000181	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CYP19A1—polycystic ovary syndrome	0.000124	0.000181	CbGpPWpGaD
Etodolac—RXRA—Metabolism—SLC2A4—polycystic ovary syndrome	0.000123	0.00018	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000122	0.000179	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	0.000122	0.000179	CbGpPWpGaD
Etodolac—PTGS2—Disease—FGF18—polycystic ovary syndrome	0.00012	0.000176	CbGpPWpGaD
Etodolac—ALB—Metabolism—STAR—polycystic ovary syndrome	0.000119	0.000175	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000119	0.000175	CbGpPWpGaD
Etodolac—PTGS2—Disease—RBP4—polycystic ovary syndrome	0.000119	0.000175	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000118	0.000173	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000118	0.000173	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	0.000117	0.000172	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000117	0.000172	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—NR3C1—polycystic ovary syndrome	0.000117	0.000171	CbGpPWpGaD
Etodolac—ALB—Hemostasis—GNAS—polycystic ovary syndrome	0.000116	0.00017	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CYP19A1—polycystic ovary syndrome	0.000115	0.000169	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—LHB—polycystic ovary syndrome	0.000115	0.000168	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	0.000113	0.000165	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000112	0.000164	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000112	0.000164	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000111	0.000163	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000111	0.000162	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GNAS—polycystic ovary syndrome	0.00011	0.000162	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—TH—polycystic ovary syndrome	0.00011	0.000161	CbGpPWpGaD
Etodolac—PTGS2—Disease—GAB1—polycystic ovary syndrome	0.00011	0.000161	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000109	0.000161	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—MTHFR—polycystic ovary syndrome	0.000109	0.00016	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000108	0.000159	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000108	0.000159	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000107	0.000157	CbGpPWpGaD
Etodolac—PTGS2—Disease—NAMPT—polycystic ovary syndrome	0.000107	0.000157	CbGpPWpGaD
Etodolac—ALB—Metabolism—HMMR—polycystic ovary syndrome	0.000106	0.000156	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000105	0.000154	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—NCOR1—polycystic ovary syndrome	0.000105	0.000154	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000103	0.000152	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GNAS—polycystic ovary syndrome	0.000103	0.000151	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000103	0.00015	CbGpPWpGaD
Etodolac—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	0.000102	0.000149	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CYP19A1—polycystic ovary syndrome	0.0001	0.000147	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.0001	0.000147	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.0001	0.000147	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	9.98e-05	0.000146	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CYP1A1—polycystic ovary syndrome	9.97e-05	0.000146	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	9.96e-05	0.000146	CbGpPWpGaD
Etodolac—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	9.81e-05	0.000144	CbGpPWpGaD
Etodolac—RXRA—Metabolism—NCOR1—polycystic ovary syndrome	9.81e-05	0.000144	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	9.78e-05	0.000144	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	9.67e-05	0.000142	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	9.66e-05	0.000142	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	9.52e-05	0.00014	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	9.5e-05	0.000139	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	9.31e-05	0.000137	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CYP1A1—polycystic ovary syndrome	9.3e-05	0.000136	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—MTHFR—polycystic ovary syndrome	9.29e-05	0.000136	CbGpPWpGaD
Etodolac—ALB—Metabolism—LHB—polycystic ovary syndrome	9.26e-05	0.000136	CbGpPWpGaD
Etodolac—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	9.06e-05	0.000133	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—PPARG—polycystic ovary syndrome	9.04e-05	0.000133	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GNAS—polycystic ovary syndrome	8.97e-05	0.000132	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—TH—polycystic ovary syndrome	8.95e-05	0.000131	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	8.95e-05	0.000131	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8.9e-05	0.000131	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PPARG—polycystic ovary syndrome	8.86e-05	0.00013	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	8.84e-05	0.00013	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.77e-05	0.000129	CbGpPWpGaD
Etodolac—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	8.77e-05	0.000129	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—POMC—polycystic ovary syndrome	8.74e-05	0.000128	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	8.72e-05	0.000128	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	8.71e-05	0.000128	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—INS—polycystic ovary syndrome	8.69e-05	0.000128	CbGpPWpGaD
Etodolac—RXRA—Metabolism—MTHFR—polycystic ovary syndrome	8.67e-05	0.000127	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—NCOR1—polycystic ovary syndrome	8.54e-05	0.000125	CbGpPWpGaD
Etodolac—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	8.4e-05	0.000123	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	8.35e-05	0.000122	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	8.32e-05	0.000122	CbGpPWpGaD
Etodolac—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	8.26e-05	0.000121	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	8.22e-05	0.000121	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	8.22e-05	0.000121	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	8.19e-05	0.00012	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—SERPINE1—polycystic ovary syndrome	8.14e-05	0.000119	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CYP1A1—polycystic ovary syndrome	8.1e-05	0.000119	CbGpPWpGaD
Etodolac—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	8.07e-05	0.000118	CbGpPWpGaD
Etodolac—PTGS2—Disease—PRL—polycystic ovary syndrome	7.88e-05	0.000116	CbGpPWpGaD
Etodolac—ALB—Metabolism—RRM2—polycystic ovary syndrome	7.82e-05	0.000115	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.79e-05	0.000114	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	7.58e-05	0.000111	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—IL6—polycystic ovary syndrome	7.57e-05	0.000111	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—MTHFR—polycystic ovary syndrome	7.55e-05	0.000111	CbGpPWpGaD
Etodolac—ALB—Metabolism—YAP1—polycystic ovary syndrome	7.53e-05	0.000111	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PPARG—polycystic ovary syndrome	7.53e-05	0.000111	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IGF1—polycystic ovary syndrome	7.5e-05	0.00011	CbGpPWpGaD
Etodolac—ALB—Hemostasis—AKT2—polycystic ovary syndrome	7.49e-05	0.00011	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—POMC—polycystic ovary syndrome	7.43e-05	0.000109	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	7.41e-05	0.000109	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—INS—polycystic ovary syndrome	7.39e-05	0.000108	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	7.31e-05	0.000107	CbGpPWpGaD
Etodolac—ALB—Metabolism—NAMPT—polycystic ovary syndrome	7.24e-05	0.000106	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.2e-05	0.000106	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	7.18e-05	0.000105	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	7.15e-05	0.000105	CbGpPWpGaD
Etodolac—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	7.12e-05	0.000105	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—TH—polycystic ovary syndrome	7.11e-05	0.000104	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.1e-05	0.000104	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PPARG—polycystic ovary syndrome	7.03e-05	0.000103	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	6.96e-05	0.000102	CbGpPWpGaD
Etodolac—RXRA—Metabolism—POMC—polycystic ovary syndrome	6.93e-05	0.000102	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	6.91e-05	0.000101	CbGpPWpGaD
Etodolac—RXRA—Metabolism—INS—polycystic ovary syndrome	6.89e-05	0.000101	CbGpPWpGaD
Etodolac—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	6.75e-05	9.91e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	6.65e-05	9.75e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	6.61e-05	9.69e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	6.6e-05	9.69e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—NCOR1—polycystic ovary syndrome	6.6e-05	9.69e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	6.5e-05	9.54e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—NRG1—polycystic ovary syndrome	6.48e-05	9.51e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	6.4e-05	9.39e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	6.17e-05	9.05e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	6.15e-05	9.03e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PPARG—polycystic ovary syndrome	6.12e-05	8.98e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—POMC—polycystic ovary syndrome	6.04e-05	8.86e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—INS—polycystic ovary syndrome	6e-05	8.81e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	5.93e-05	8.7e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.89e-05	8.64e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	5.85e-05	8.59e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MTHFR—polycystic ovary syndrome	5.83e-05	8.56e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.81e-05	8.53e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	5.8e-05	8.52e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—TH—polycystic ovary syndrome	5.75e-05	8.44e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	5.59e-05	8.21e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—IRS2—polycystic ovary syndrome	5.55e-05	8.14e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	5.53e-05	8.11e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	5.53e-05	8.11e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	5.44e-05	7.98e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	5.26e-05	7.72e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	5.24e-05	7.69e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	4.99e-05	7.32e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—POMC—polycystic ovary syndrome	4.92e-05	7.22e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	4.9e-05	7.19e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—INS—polycystic ovary syndrome	4.89e-05	7.18e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	4.89e-05	7.17e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—IRS1—polycystic ovary syndrome	4.84e-05	7.11e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—TH—polycystic ovary syndrome	4.71e-05	6.91e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GNAS—polycystic ovary syndrome	4.69e-05	6.89e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—INS—polycystic ovary syndrome	4.64e-05	6.81e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	4.58e-05	6.72e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKT2—polycystic ovary syndrome	4.48e-05	6.58e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—NCOR1—polycystic ovary syndrome	4.47e-05	6.56e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	4.31e-05	6.32e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	4.26e-05	6.25e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	4.24e-05	6.22e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	3.96e-05	5.81e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—MTHFR—polycystic ovary syndrome	3.95e-05	5.8e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—POMC—polycystic ovary syndrome	3.91e-05	5.73e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—INS—polycystic ovary syndrome	3.89e-05	5.7e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	3.84e-05	5.64e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	3.66e-05	5.37e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	3.47e-05	5.09e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	3.24e-05	4.75e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PPARG—polycystic ovary syndrome	3.21e-05	4.7e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—POMC—polycystic ovary syndrome	3.16e-05	4.64e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—INS—polycystic ovary syndrome	3.14e-05	4.61e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.62e-05	3.85e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.59e-05	3.8e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.57e-05	3.78e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—IL6—polycystic ovary syndrome	2.03e-05	2.98e-05	CbGpPWpGaD
